Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
10.6M
-
Shares change
-
-58.5K
-
Total reported value, excl. options
-
$26M
-
Value change
-
-$224K
-
Put/Call ratio
-
0
-
Number of buys
-
16
-
Number of sells
-
-23
-
Price
-
$2.45
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q1 2022
54 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q1 2022.
Summit Therapeutics Inc. - COM (SMMT) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.6M shares
.
Largest 10 shareholders include Polar Capital Holdings Plc (6.27M shares), BlackRock Inc. (1.37M shares), VANGUARD GROUP INC (911K shares), BAILLIE GIFFORD & CO (437K shares), STATE STREET CORP (313K shares), GEODE CAPITAL MANAGEMENT, LLC (257K shares), NORTHERN TRUST CORP (176K shares), BOOTHBAY FUND MANAGEMENT, LLC (155K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (129K shares), and UBS Group AG (82.2K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.